Follow
Michele Cavo
Michele Cavo
Professor of Hematology
Verified email at unibo.it
Title
Cited by
Cited by
Year
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
48372014
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
24132016
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...
Journal of clinical oncology 33 (26), 2863, 2015
20952015
Idecabtagene vicleucel in relapsed and refractory multiple myeloma
NC Munshi, LD Anderson Jr, N Shah, D Madduri, J Berdeja, S Lonial, ...
New England Journal of Medicine 384 (8), 705-716, 2021
13392021
Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma
P Moreau, T Masszi, N Grzasko, NJ Bahlis, M Hansson, L Pour, I Sandhu, ...
New England Journal of Medicine 374 (17), 1621-1634, 2016
12032016
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ...
Leukemia 23 (2), 215-224, 2009
10172009
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414-423, 2008
10132008
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …
J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...
The lancet oncology 14 (11), 1055-1066, 2013
10062013
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
10062012
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem …
M Cavo, P Tacchetti, F Patriarca, MT Petrucci, L Pantani, M Galli, ...
The Lancet 376 (9758), 2075-2085, 2010
9712010
Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma
MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ...
New England Journal of Medicine 378 (6), 518-528, 2018
9472018
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
A Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...
New England Journal of Medicine 366 (19), 1759-1769, 2012
9082012
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
L Benboubker, MA Dimopoulos, A Dispenzieri, J Catalano, AR Belch, ...
New England Journal of Medicine 371 (10), 906-917, 2014
9022014
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
8912014
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types
C Rapezzi, G Merlini, CC Quarta, L Riva, S Longhi, O Leone, F Salvi, ...
Circulation 120 (13), 1203-1212, 2009
8322009
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ...
Annals of oncology 28, iv52-iv61, 2017
8312017
IMWG consensus on risk stratification in multiple myeloma
WJ Chng, A Dispenzieri, CS Chim, R Fonseca, H Goldschmidt, ...
Leukemia 28 (2), 269-277, 2014
6682014
Proteasome inhibitors in multiple myeloma: 10 years later
P Moreau, PG Richardson, M Cavo, RZ Orlowski, JF San Miguel, ...
Blood, The Journal of the American Society of Hematology 120 (5), 947-959, 2012
6232012
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …
M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...
The Lancet 394 (10214), 2096-2107, 2019
597*2019
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
E Zamagni, F Patriarca, C Nanni, B Zannetti, E Englaro, A Pezzi, ...
Blood, The Journal of the American Society of Hematology 118 (23), 5989-5995, 2011
5652011
The system can't perform the operation now. Try again later.
Articles 1–20